Clearmind Medicine Sets Jan 6 Shareholder Meeting
Ticker: CMND · Form: 6-K · Filed: Nov 20, 2024 · CIK: 1892500
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance, filing-update
Related Tickers: CMND
TL;DR
Clearmind Medicine (CMND) holding shareholder meeting Jan 6, record date Nov 28. Vote matters!
AI Summary
Clearmind Medicine Inc. announced on November 20, 2024, that its Annual and Special Meeting of Shareholders will be held on January 6, 2025. The record date for determining shareholders eligible to vote is November 28, 2024. Following this record date, the company will distribute proxy materials and a proxy card.
Why It Matters
This meeting is crucial for shareholders to vote on company matters and influence its future direction. The record date determines who has the right to participate in this important decision-making process.
Risk Assessment
Risk Level: low — This filing is a routine announcement of a shareholder meeting and does not contain significant financial or operational news.
Key Players & Entities
- Clearmind Medicine Inc. (company) — Registrant
- January 6, 2025 (date) — Annual and Special Meeting date
- November 28, 2024 (date) — Record date for meeting eligibility
- November 20, 2024 (date) — Date of announcement
FAQ
When will Clearmind Medicine Inc. hold its Annual and Special Meeting of Shareholders?
The meeting is scheduled for January 6, 2025.
What is the record date for the Clearmind Medicine Inc. shareholder meeting?
The record date is November 28, 2024.
What will be distributed to shareholders after the record date?
Proxy materials, including proposed resolutions, and a proxy card will be distributed.
What type of issuer is Clearmind Medicine Inc. filing as?
Clearmind Medicine Inc. is filing as a Foreign Private Issuer.
Which form does Clearmind Medicine Inc. file annually?
Clearmind Medicine Inc. files annual reports under cover of Form 20-F.
Filing Stats: 307 words · 1 min read · ~1 pages · Grade level 11.2 · Accepted 2024-11-20 16:01:03
Filing Documents
- ea0221981-6k_clearmind.htm (6-K) — 12KB
- ea022198101ex99-1_clear.htm (EX-99.1) — 5KB
- ex99-1_001.jpg (GRAPHIC) — 10KB
- 0001213900-24-100543.txt ( ) — 32KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Clearmind Medicine, Inc. (Registrant) Date: November 20, 2024 By: /s/ Adi Zuloff-Shani Name: Adi Zuloff-Shani Title: Chief Executive Officer 3